Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Core Laboratories Inc. (CLB) had Stock-Based Compensation of $7.14M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$138.25M |
|
$7.08M |
|
$109.52M |
|
$28.74M |
|
$122.42M |
|
$15.83M |
|
$-2.61M |
|
$13.22M |
|
$13.22M |
|
$7.26M |
|
$7.26M |
|
$7.26M |
|
$7.26M |
|
$15.83M |
|
-- |
|
-- |
|
46.70M |
|
-- |
|
$0.16 |
|
| Balance Sheet Financials | |
$222.37M |
|
$99.45M |
|
$374.59M |
|
$596.95M |
|
$107.17M |
|
$110.25M |
|
$210.02M |
|
$317.19M |
|
-- |
|
$58.97M |
|
$279.76M |
|
-- |
|
| Cash Flow Statement Financials | |
$37.18M |
|
$-2.23M |
|
$-31.25M |
|
$19.16M |
|
$22.85M |
|
$3.69M |
|
|
Stock-Based Compensation |
$7.14M |
$-1.87M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|